Peripheral Artery Disease: Incidence and Outcomes of Myocardial Infarction
Myocardial infarction was associated with an increased risk of cardiovascular death and
acute limb ischemia in patients with peripheral artery disease.
Myocardial infarction was associated with an increased risk of cardiovascular death and
acute limb ischemia in patients with peripheral artery disease.
Phase 3 EINSTEIN CHOICE study shows Xarelto 10mg reduced the risk of recurrent VTE by 74%
Eliot Brinton, MD, FAHA, FNLA, president and director of the Utah Lipid Center, discusses the benefits of fasting lipid profiles in predicting cardiovascular risk.
Highlights from the 2017 American College of Cardiology Scientific Session & Expo.
Both iFR and FFR groups experienced similar rates of composite nonfatal myocardial infarction, unplanned revascularization, or all-cause death within 1 year post-procedure.
Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.
Inadequate therapeutic anticoagulation prior to the occurrence of ischemic stroke was found to be prevalent.
Although more women are admitted with Takotsubo cardiomyopathy, more men ultimately die.
Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.
Researchers found that same-day discharge in PCI for non-ST-segment elevation acute coronary syndromes.